mRNA |
ML258 |
CTRPv2 |
pan-cancer |
AAC |
-0.0086 |
0.8 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0074 |
0.8 |
mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
-0.0099 |
0.8 |
mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
-0.0073 |
0.8 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0063 |
0.8 |
mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
-0.0086 |
0.8 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
-0.0082 |
0.8 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0077 |
0.8 |
mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.0077 |
0.8 |
mRNA |
RAF265 |
CCLE |
pan-cancer |
AAC |
0.011 |
0.8 |